{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-007912","form_type":"8-K","ticker":"AEMD","cik":"0000882291","company_name":"AETHLON MEDICAL INC","filed_at":"2023-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.232289+00:00","generated_at":"2026-06-08T05:56:33.882429+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Aethlon Medical appoints James B. Frakes as Interim CEO; Charles J. Fisher Jr. departs","bullets":["Charles J. Fisher Jr., M.D. departed as CEO effective Nov 7, 2023; Guy F. Cipriani resigned as director.","James B. Frakes appointed as Interim CEO and Board member, retains CFO role.","Guy F. Cipriani appointed as Senior VP and COO; resigned from Board.","Frakes' base salary $360,000 (set Jan 2023); eligible for discretionary bonus.","Company plans amended employment agreements for Frakes and Cipriani."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-007912","json":"https://secwatch.observer/filing/0001683168-23-007912.json","markdown":"https://secwatch.observer/filing/0001683168-23-007912.md","text":"https://secwatch.observer/filing/0001683168-23-007912.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882291/000168316823007912/0001683168-23-007912-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882291/000168316823007912/aethlon_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T05:56:33.882429+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"314b582539","claim":"Charles J. Fisher, Jr., M.D. departed as Chief Executive Officer at AETHLON MEDICAL INC.","evidence_excerpt":"(b) Departure of Charles J. Fisher, Jr., M.D. as Chief Executive Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316823007912/0001683168-23-007912-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"743137d0c8","claim":"Guy F. Cipriani was appointed as Senior Vice President and Chief Operating Officer at AETHLON MEDICAL INC.","evidence_excerpt":"Guy F. Cipriani, formerly Senior Vice President and Chief Business Officer of the Company, (i) was appointed as the Company’s Senior Vice President and Chief Operating Officer and (ii) resigned from the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316823007912/0001683168-23-007912-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Senior Vice President and Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"782562f241","claim":"James B. Frakes was appointed as Director at AETHLON MEDICAL INC.","evidence_excerpt":"Effective November 7, 2023, James B. Frakes, Chief Financial Officer of Aethlon Medical, Inc. (the “Company”), was appointed as (i) Interim Chief Executive Officer of the Company, replacing Charles J. Fisher, Jr. M.D., and (ii) a member of the Board of Directors of the Company (the “Board”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316823007912/0001683168-23-007912-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"89c447dd76","claim":"James B. Frakes was appointed as Interim Chief Executive Officer at AETHLON MEDICAL INC.","evidence_excerpt":"Effective November 7, 2023, James B. Frakes, Chief Financial Officer of Aethlon Medical, Inc. (the “Company”), was appointed as (i) Interim Chief Executive Officer of the Company, replacing Charles J. Fisher, Jr. M.D., and (ii) a member of the Board of Directors of the Company (the “Board”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316823007912/0001683168-23-007912-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"db6dc4e3e7","claim":"Guy F. Cipriani resigned as Director at AETHLON MEDICAL INC.","evidence_excerpt":"Guy F. Cipriani, formerly Senior Vice President and Chief Business Officer of the Company, (i) was appointed as the Company’s Senior Vice President and Chief Operating Officer and (ii) resigned from the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316823007912/0001683168-23-007912-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}